Oxford Nanopore said in its registration filing that it serves customers in more than 100 countries. Researchers are using the Group’s DNA/RNA sequencing technology for purposes that include analyzing human, cancer, plant, microbial/pathogen, food and/or environmental samples. The company’s tools and technologies have been written up to date in more than 2,100 scientific publications including preprints. Oxford Nanopore said it owns or in-licenses more than 2,000 patents and applications including 800 generated internally across more than 260 patent families.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed